Kayli Gallen, MOT,OTR/L in Jane Lew, WV - Occupational Therapist

Kayli Gallen, MOT,OTR/L is a Occupational Therapist based in Jane Lew, West Virginia. Kayli Gallen is licensed to practice in West Virginia (license number 2120) and her current practice location is 199 Court St, Jane Lew, West Virginia. She can be reached at her office (for appointments etc.) via phone at (304) 884-7811.

NPI number for Kayli Gallen is 1295384097 and her current mailing address is 59 Sioux Dr, Buckhannon, West Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1295384097.

Contact Information

	Kayli Gallen, MOT,OTR/L
	199 Court St, Jane Lew, WV 26378-8548
	(304) 884-7811
	Not Available

Healthcare Provider's Profile

Full Name	Kayli Gallen
Gender	Female
Speciality	Occupational Therapist
Location	199 Court St, Jane Lew, West Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1295384097
Provider Enumeration Date: 09/05/2019
Last Update Date: 12/29/2021

Medical Identifiers

Medical identifiers for Kayli Gallen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295384097	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	2120 (West Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kayli Gallen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kayli Gallen, MOT,OTR/L 59 Sioux Dr, Buckhannon, WV 26201-1242 Ph: (267) 567-2793	Kayli Gallen, MOT,OTR/L 199 Court St, Jane Lew, WV 26378-8548 Ph: (304) 884-7811

News Archive

Medtronic initiates enrollment in Enlite Sensor study for diabetes

Medtronic, Inc. today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite Sensor, the company's latest innovation in continuous glucose monitoring (CGM) technology for people with diabetes.

NRC, AvidBiologics partner to develop three novel ADCs for treatment of cancer

AvidBiologics Inc., a life sciences company developing antibody-drug conjugates (ADCs), announces the conclusion of an agreement with the National Research Council Canada (NRC) to develop three novel ADCs for the treatment of cancer.

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA), with a goal date of March 26, 2012 under the Prescription Drug User Fee Act (PDUFA).

New less expensive method to enrich stable isotopes

Researchers at The University of Texas at Austin have devised a new method for enriching a group of the world's most expensive chemical commodities, stable isotopes, which are vital to medical imaging and nuclear power, as reported this week in the journal Nature Physics. For many isotopes, the new method is cheaper than existing methods. For others, it is more environmentally friendly.

In Virginia, budget negotiators still wrestling with Medicaid expansion plan

Virginia legislators must come to terms on the state budget blueprint by the legislative session's scheduled March 8 conclusion. The expansion debate also stays hot in Utah and Arkansas.

Kayli Gallen, MOT,OTR/L - Occupational Therapist in Jane Lew, WV